BIOSCRIP INC's ticker is BIOSXXXX and the CUSIP is 09069N108. A total of 114 filers reported holding BIOSCRIP INC in Q3 2018. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2018 | $6,000 | – | 2,197 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RIVULET CAPITAL, LLC | 1,400,000 | $11,676,000 | 9.66% |
| DSC Advisors, L.P. | 3,150,000 | $26,272,000 | 7.40% |
| Consonance Capital Management LP | 3,950,839 | $32,950,000 | 4.90% |
| NFC Investments, LLC | 951,580 | $7,936,000 | 3.88% |
| PRESCOTT GROUP CAPITAL MANAGEMENT, L.L.C. | 2,090,789 | $17,437,000 | 3.07% |
| KEANE CAPITAL MANAGEMENT INC | 310,000 | $2,585,000 | 2.41% |
| First Washington CORP | 454,200 | $3,788,000 | 2.12% |
| GLENHILL ADVISORS LLC | 2,486,490 | $20,737,000 | 1.68% |
| ARDSLEY ADVISORY PARTNERS LP | 1,500,000 | $12,510,000 | 1.60% |
| True Bearing Asset Management LP | 357,161 | $2,979,000 | 1.55% |